Abortion Worldwide
The Institute’s work around abortion worldwide, authored in collaboration with the UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), examines incidence by women’s income and by the legal status of abortion, from 1990 to 2019. The project provides
Global Abortion Incidence Data Set all publicly available abortion data for 1990–2018, as well as information on data sources and quality, representing the first global compilation of national-level abortion incidence data
Pregnancies, Births and Abortions in the United States
The Institute compiles comprehensive statistics on the incidence of pregnancy, birth and abortion for people in all reproductive age-groups in the United States at the national level (1973–2017) and state level (1988–2017).
The decision to offer the under-30s an alternative to the AstraZeneca vaccine over blood clotting concerns has had no impact on people’s intention of getting the jab, new research suggests.
New UK guidance was issued on April 7 recommending that people aged 18 to 29 should be offered the Pfizer or Moderna vaccines after the Medicines and Healthcare products Regulatory Agency (MHRA) said there is a possible link between the AstraZeneca jab and “extremely rare” blood clots.
Several European countries including France, Germany and Italy suspended use of the vaccine in March over the link, although they later said they would resume its rollout.
MHRA regulator ruled this month that under-30s should be given a different jab
Survey of people aged 30 to 40 found they were not put off vaccination by news
They were close in age to those affected by rule but old enough to get AZ jab
Reputation of AstraZeneca s vaccine has suffered in Europe and Africa
Scientists say it appears to increase the risk of a very rare blood clotting illness
Wed, 21st Apr 2021 11:50
(Alliance News) - The decision to offer the under-30s an alternative to the AstraZeneca PLC vaccine over blood clotting concerns has had no impact on people s intention of getting the jab, new research suggests.
New UK guidance was issued on April 7 recommending that people aged 18 to 29 should be offered the Pfizer or Moderna vaccines after the Medicines and Healthcare products Regulatory Agency said there is a possible link between the AstraZeneca jab and extremely rare blood clots.
Several European countries including France, Germany and Italy suspended use of the vaccine in March over the link, although they later said they would resume its rollout.
AstraZeneca Jab: guidance change for under-30s has not caused hesitancy thisisoxfordshire.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thisisoxfordshire.co.uk Daily Mail and Mail on Sunday newspapers.